The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design.
about
Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar.A profound computational study to prioritize the disease-causing mutations in PRPS1 gene.Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling.
P2860
The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The impact of Thr91 mutation o ...... w opportunity for drug design.
@ast
The impact of Thr91 mutation o ...... w opportunity for drug design.
@en
type
label
The impact of Thr91 mutation o ...... w opportunity for drug design.
@ast
The impact of Thr91 mutation o ...... w opportunity for drug design.
@en
prefLabel
The impact of Thr91 mutation o ...... w opportunity for drug design.
@ast
The impact of Thr91 mutation o ...... w opportunity for drug design.
@en
P2860
P356
P1433
P1476
The impact of Thr91 mutation o ...... w opportunity for drug design.
@en
P2093
Ndumiso N Mhlongo
Umar Ndagi
P2860
P304
P356
10.1039/C6MB00848H
P577
2017-05-02T00:00:00Z